Coughlin Timothy 4
4 · ADC Therapeutics SA · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
ADC Therapeutics (ADCT) Director Timothy Coughlin Receives RSUs, Sells Shares
What Happened
Timothy Coughlin, a director of ADC Therapeutics (ADCT), received an award of 45,000 restricted stock units (RSUs) on 2026-06-01 (recorded at $0.00 per share for the grant). Separately, on 2026-06-03 the company withheld 12,600 shares (disposed) at $3.08 each to satisfy tax withholding obligations related to previously vested RSUs, totaling $38,808. The RSU grant vests on the earlier of one year from the grant date or the 2027 Annual Meeting, subject to continued service.
Key Details
- Transactions:
- 2026-06-01 — Award/Grant (Code A): 45,000 RSUs @ $0.00 (acquired). Each RSU equals a contingent right to one share.
- 2026-06-03 — Tax withholding (Code F): 12,600 shares withheld/disposed @ $3.08 = $38,808 (to satisfy tax withholding on prior RSU vesting).
- Shares owned after transaction: Not specified in the filing.
- Footnotes:
- F1: Annual director RSU grant; vests the earlier of one year or the 2027 Annual Meeting, subject to continued service.
- F2: The 12,600 shares were withheld by the issuer to cover tax withholding on previously granted RSUs.
- Filing timeliness: Report filed 2026-06-03 for a 2026-06-01 grant—appears to be filed within the normal Form 4 reporting window.
Context
RSU grants are compensation awards (not open-market purchases) and typically reflect routine director compensation. The withheld shares represent a common tax-withholding mechanism (shares are surrendered to cover tax obligations) and should not be read as a discretionary sale signal about company prospects.
Insider Transaction Report
- Award
Common Shares
[F1]2026-06-01+45,000→ 85,000 total - Tax Payment
Common Shares
[F2]2026-06-03$3.08/sh−12,600$38,808→ 72,400 total
Footnotes (2)
- [F1]Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted.